Combined PARP and Immune Checkpoint Inhibition in Ovarian Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference12 articles.
1. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: interim results from the Phase 2 KEYNOTE-100 study;Matulonis;J. Clin. Oncol.,2018
2. Efficacy and safety of avelumab for patients with recurrent or refractory ovarian cancer;Disis;JAMA Oncol.,2019
3. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer;Konstantinopoulos;Cancer Discov.,2015
4. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer;Goode;JAMA Oncol.,2017
5. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer;Strickland;Oncotarget,2016
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial;Journal of Clinical Oncology;2024-01-20
2. Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer;Seminars in Cancer Biology;2023-11
3. The role of immune checkpoint inhibition in triple negative breast cancer;Expert Review of Anticancer Therapy;2023-10-03
4. PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities;Drug Discovery Today;2023-08
5. CD4 T cells and toxicity from immune checkpoint blockade;Immunological Reviews;2023-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3